pharmaphorum

NOVEMBER 9, 2021

Once widely acknowledged as so special that only scientists and clinical specialists need to apply, oncology has become exponentially more clinically targeted and sophisticated over the last decade. The success of branding in immuno-oncology. Michael Gaschler, PhD , Senior Consultant, Oncology, Cerner Enviza.

Cerner 98

Cerner 98

PharmaState Academy

MARCH 15, 2023

The webinar was attended by numerous Pharma Marketing, Digital & Medical Affairs professionals. The webinar was attended by numerous Pharma Marketing, Digital & Medical Affairs professionals. The attendees found the webinar to be highly informative, and they appreciated the ideas and suggestions shared by the speakers.

52

52

Pharma Marketing Network

DECEMBER 29, 2020

As telehealth appointments replaced office visits, webinars replaced in-person conferences and digital communication replaced reps in the field, what have we learned about how to create connection within this new paradigm? Ryan Billings , Head, US Oncology Digital Marketing & Customer Experience at GSK. SAVE MY SEAT.

Communication 98

Communication 98

pharmaphorum

FEBRUARY 24, 2022

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), will be held Wednesday 23rd March at 15:00 GMT / 16:00 CET. The webinar will cover: What new kinds of data is available to commercial researchers. Ed Merivale is therapy relationship manager, oncology at NIHR.

Hospitals 104

Hospitals 104

Drug Channels

DECEMBER 14, 2023

This week, I’m rerunning some popular posts while I prepare for tomorrow’s Drug Channels Outlook 2024 live video webinar. In case you haven’t noticed, private equity firms have displaced hospitals and health systems as the major acquirers of community oncology practices. Click here to see the original post from October 2023.

Hospitals 52

Hospitals 52

Drug Channels

DECEMBER 18, 2020

This week, I’m rerunning some popular posts while I prepare for today's video webinar: Drug Channels Outlook 2021. See below for detailed data on oncology and non-oncology products. Click here to see the original post and comments from September 2020.

Specialty Pharmacies 52

Specialty Pharmacies Physician Offices Hospitals 52

pharmaphorum

SEPTEMBER 28, 2020

pharmaphorum’s Behavioural insights into haem/onc clinical decision making webinar, in association with Medscape, showed that this can negatively impact physicians’ confidence as they try and keep on top of information about an array of treatment options. Data from the US cited during the webinar showed a five-year survival rate of 34.2%

Biosimilars 104

Biosimilars Hospitals 104

Putting Patients First Blog

MAY 26, 2023

ET Event Location: Virtual The National Health Council invites you to join us for a webinar on the latest developments with biosimilars on Monday, June 12 at 2 p.m. Biosimilars briefing Event Time: 2:00 - 3:00 p.m. across broader disease areas.

Biosimilars 52

Biosimilars Communication 52

Drug Channels

NOVEMBER 24, 2020

My recent tweets have highlighted: doctors against step therapy, distribution of COVID-19 therapies, biosimilar savings, copay accumulator data, prospects for smaller PBMs, the new transparency rule, specialty pharmacy profit metrics, the future of oncology practices, and an update on Diplomat founder Phil Hagerman. to 1:15 p.m.

Specialty Pharmacies 52

Specialty Pharmacies Biosimilars Hospitals 52

pharmaphorum

OCTOBER 30, 2019

Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. Traditional utilization management tools are still difficult to apply in oncology, given no payer wants to be on the front page of a major newspaper for denying treatment. Pathways have not held up to their promise for containing cost.

Chemotherapy 40

Chemotherapy 40

Drug Channels

MARCH 22, 2021

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Quarterly Update: Patients, Payers, and PBMs. Expect much more controversy as exclusions hit previously untouched but sensitive sole-source products in oncology, rheumatology, and beyond—and even start moving into Medicaid.

52

52

pharmaphorum

JUNE 27, 2016

The ASCO Annual Meeting, the largest global oncology meeting and increasingly the centre of a kaleidoscope of social media coverage each year. This webinar will examine the conversation around ASCO 2016, its relationship with ASCO, value to and involvement from stakeholder groups and how it will potentially continue to evolve into 2017.

52

52

pharmaphorum

FEBRUARY 11, 2016

The first in a trilogy of webinars focussed on the topic; Unlocking the value; the economic equation and part of the IMS Health Practical Insights series. Answering this paradigm is where real world evidence can step in.

Drug Development 52

Drug Development 52

pharmaphorum

DECEMBER 21, 2021

In a recent webinar held by pharmaphorum, in partnership with IQVIA, a discussion was held looking at how to make academic and commercial medical research more efficient, while also looking at the opportunity of genomic data to bring benefits to patients and healthcare systems.

Drug Development 98

Drug Development Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

Pharma Marketing Network

FEBRUARY 4, 2021

Oncology Digital Marketing & Customer Experience at GSK. Watch the full webinar here to get in-depth responses from this great group of panelists. The post Webinar Recap – Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience with PMN appeared first on Pharma Marketing Network.

98

98

pharmaphorum

MARCH 10, 2017

We also see member states working to understand the process of enabling cost-effective patient access to personalised and high-cost treatments, such as new oncology combination therapies, antibiotics and stem cell therapies, which offer the promise of efficacy in key disease areas.

Drug Development 52

Drug Development 52

epicur

AUGUST 8, 2023

We partner with experts to offer educational webinars that ensure you understand the impact on your practice. Watch our most recent on-demand GFI webinar with Nicole Clausen, What Every Inventory Manager Needs to Know About Compounded Medications. Our team is dedicated to helping you stay up to date on regulation changes.

Compounding 52

Compounding Documentation Compounding Pharmacies Packaging 52

pharmaphorum

JANUARY 26, 2023

“Any focus on improving patient access to innovative medicines – especially for rare and ultra-rare diseases – is extremely welcome,” said Sean Richardson, VP and general manager UK & Ireland, Alexion during a recent pharmaphorum webinar. That showed that collaboration can deliver,” McFarlane concluded.

57

57

Safe Biologics

FEBRUARY 1, 2024

the initial period, the uptake of biosimilars was extremely limited, with most commercial plans preferring the originator on their formulary.

Biosimilars 130

Biosimilars Documentation Drug Pricing 130

pharmaphorum

MARCH 21, 2022

In this webinar, we will discuss the challenges CEOs face and their personal journey during this exciting stage of entrepreneurship. This webinar will cover: Key success factors. Panel discussions will be based around the recent publication The Digital Health Start-up Journey: From Series A to scaling up. Post-Series A challenges.

Hospitals 145

Hospitals Pharmaceutical Companies Pharmaceutical Companies 145

pharmaphorum

JANUARY 27, 2021

Information from the ‘cradle to grave’ care it provides has tremendous potential for driving more research within the UK, notably in oncology, with patients, regulators, payers, researchers, clinicians and the NHS itself all likely to benefit. In the current environment, it can also measure the impact of COVID-19 on oncology pathways.

Hospitals 143

Hospitals Chemotherapy Vaccines 143

pharmaphorum

SEPTEMBER 30, 2021

We are also highlighting the enduring importance of research, which has not only impacted the treatment of blood cancer but has triggered insights across oncology. Help and support for blood cancer patients. This month we’ve also launched a range of material for people who’ve been newly diagnosed.

Vaccines 52

Vaccines Communication 52

Drug Channels

JUNE 19, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. I want to wish everyone a happy Juneteenth! Click here to see the original post from February 2023. Check out the plan and patient data below.

75

75

pharmaphorum

OCTOBER 7, 2021

However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. He also serves as haematology consultant to the NICU and genetics service and is co-director of the NIH/Johns Hopkins Pediatric Hematology/Oncology Fellowship Program.

Hospitals 98

Hospitals 98

pharmaphorum

MAY 18, 2022

This was the focus of a recent pharmaphorum webinar , held in association with the National Institute of Health and Care Research (NIHR) where experts from the NIHR and Roche discussed the potential of healthcare data in commercial clinical research. Ed Merivale is therapy relationship manager, oncology at Roche.

Diabetes 80

Diabetes Hospitals 80

FDA Law Blog: Biosimilars

DECEMBER 11, 2023

During the October 31, 2023 webinar discussing the proposed rule, stakeholders sought clarity from FDA officials on the Agency’s plan to address the resource gap. FDA, Transcript of CDRH Webinar regarding Proposed Rule: Medical Devices; Laboratory Developed Tests, at 9-10 (Oct. 31, 2023), [link]. [10] 11] Jeffrey N. Gibbs, Allyson B.

Research Laboratories 69

Research Laboratories Documentation 69

Pharma Marketing Network

NOVEMBER 19, 2020

In this webinar, the Association of Medical Media (AMM) gave industry leaders a chance to share how their organizations are responding to the challenges of the unique environment we are currently living in. Lori and Jim stayed on to answer viewers’ questions after the webinar completed its agenda.

Physician Offices 98

Physician Offices Communication 98

Pharmaceutical Technology

FEBRUARY 13, 2023

Candidate selection case study: Progression of small molecule ‘developability’ Background: A US biotech company had identified nine structurally related compounds as potential candidates in an oncology discovery program. Quotient Sciences was asked to select the best candidate based on material science and oral bioavailability considerations.

Compounding 52

Compounding Drug Development Dosage 52

PharmaState Academy

MARCH 17, 2023

Register Now Speakers Dr. Santosh Jha Head Medical Affairs, Oncology at Growth Emerging Markets Region, Takeda Pharma. Submit The post KAM (Key Account Management Webinar) appeared first on PharmaState Academy. Identifying the touch points and customizing them for omnichannel engagements. Improving ROI with Omnichannel approach.

Packaging 52

Packaging 52

Pharmaceutical Technology

MARCH 17, 2023

Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex Watt, GlobalData’s principal research analyst, at a recent webinar on the same topic. Between 2012 and 2022, the number of oncology risk sharing agreements increased massively by 498%.

Communication 102

Communication Pharmaceutical Companies Pharmaceutical Companies 102

Pharmaceutical Technology

MAY 23, 2023

Oncology was the main therapy area, accounting for 218 trials, followed by central nervous system drugs having 185, and infectious diseases next with 138. Oncology remains the highest indication area with eight trials, with ophthalmology next at six. To learn more about the clinical trial services in Ukraine, access the webinar below.

Communication 52

Communication 52